Benjamin Graham fit · Inversión deep-value defensiva
Is Soleno Therapeutics, Inc. Common Stock (SLNO) a Benjamin Graham Stock?
Meets only 4/7 Graham criteria — likely overpriced or unstable.
20/100
FNo encaja
4/7 criterios cumplidos
Los criterios de Benjamin Graham, aplicados a SLNO
P/E ≤ 15
clave—
P/B ≤ 1.5
clave0.0x
Current ratio ≥ 2
16.1x
Debt / Equity ≤ 1
0.0x
Cómo se valora SLNO en otras estrategias
Datos financieros en vivo
Cap. mercado
$2.76B
PER (TTM)
28.7x
ROIC (TTM)
15.35%
Margen bruto
98.63%
Otros análisis Benjamin Graham
Preguntas frecuentes
What is SLNO's Benjamin Graham fit score?
SLNO scores 20/100 on our Benjamin Graham fit engine — grade F. Meets only 4/7 Graham criteria — likely overpriced or unstable.
Does Benjamin Graham actually own SLNO?
Our score is computed from financial fundamentals against Benjamin Graham's published criteria. We don't claim that Benjamin Graham personally owns or recommends SLNO.
How often is this score updated?
SLNO's Benjamin Graham fit score is recomputed daily from the latest TTM financials.
Herramienta educativa, no es asesoramiento financiero. Las puntuaciones se calculan a partir de datos financieros públicos contra los criterios publicados de cada estrategia de inversión. No afirmamos que Benjamin Graham posea o recomiende SLNO personalmente.